TP-03
TRS-008
Phase 2 small_molecule completed
Quick answer
TP-03 for Meibomian Gland Dysfunction is a Phase 2 program (small_molecule) at Tarsus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tarsus Pharmaceuticals
- Indication
- Meibomian Gland Dysfunction
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed